Latest Posts

Legal Medical Cannabis Displacing Alcohol Use?

Follow Us!Share This!The impact of medical cannabis on prescription drug use is becoming well known. Research presented at the Eleventh National Clinical Conference on Cannabis Therapeutics showed that the legal availability of medical cannabis has led many people to reduce their use of opioids and other prescribed medications, and also that the number of prescriptions being written for opioids, anti-depressants, sleeping pills, and some other medications appears to have declined in states with medical marijuana laws. So what about the…
Read more

Alcohol, News, Public Policy

House Votes To Keep Medical Cannabis Protections In Place Until Dec 22

Follow Us!Share This!The US House of Representatives on Thursday, Dec. 7, 2017, voted to keep protections in place that prevent the Department of Justice from going after state-legal medical cannabis businesses. The bill they approved is not the annual appropriations bill, rather it is a continuing resolution that only keeps the federal government funded and operating through December 22. The Rohrabacher-Blumenauer Amendment is a “rider” that was added to the Commerce, Justice Science, and Related Agencies appropriations legislation. That bill…
Read more

Cannabis Industry, News, Public Policy, State Laws

Medical Cannabis as a Substitute for Prescription Drugs

Follow Us!Share This!Evidence continues to mount that medical cannabis is a viable substitute for several types of prescription medication, including opioid painkillers, anti-anxiety drugs, and sleeping medications. In November 2017, the journal PLOS One published research results out of the New Mexico Medical Marijuana Program (“Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study“) that found “a strong correlation between enrollment in an MCP and cessation or reduction of opioid use. From a…
Read more

Cannabis Research, Continuing Education Seminar, Medical Cannabis, National Clinical Conference, Opioids and Other Prescription Drugs, Public Policy, Therapeutic Effects

FDA Sends Warning Letters To CBD Companies About Health Claims

Follow Us!Share This!On October 31, the US Food and Drug Administration sent warning letters to several companies involved in selling products that are reported to contain CBD, over health claims being made by the sellers about their products. According to the FDA: The FDA has grown increasingly concerned at the proliferation of products claiming to treat or cure serious diseases like cancer. In this case, the illegally sold products allegedly contain cannabidiol (CBD), a component of the marijuana plant that…
Read more

Cannabis Industry, News, Public Policy

, ,

Give NFL Players the Option of Medical Cannabis

Follow Us!Share This!Some may claim they just want to get high, yet the players will tell you that cannabis is their medicine; it is the best medicine for their pain and injuries resulting from the numerous hits they take. Frequent hits to the head create cumulative damage that results in serious brain disease called chronic traumatic encephalopathy. Body slams and tackles result in aches and pains throughout the body. These injuries are not limited to football – think of athletes who…
Read more

Medical Cannabis, NFL, Public Policy, State Laws, Therapeutic Effects, Video On Demand

,

Patients Out of Time Video Series Now Available!

Follow Us!Share This!Patients Out of Time’s national clinical conferences on cannabis therapeutics feature the world’s leading cannabis researchers, who explain how cannabis helps heal the brain after acute trauma; how cannabis as a pain treatment can reduce the risks from opioid use; cannabis use with geriatric patients; cannabis for PTSD, and much, much more. For the first time, we are now making these videos available to the public to stream on demand. Details are at our video on demand page. Eben…
Read more

Medical Cannabis

Nashville Oct 2017: The Endocannabinoid System and Medical Cannabis

Follow Us!Share This!First time ever in Tennessee! 6 CEU Credits for Nurses Join us on Saturday, October 14 in beautiful downtown Nashville to learn more on the ground-breaking advancements of how cannabis is offering a better quality of life to patients. Learning Objectives: Identify the major components of the Endocannabinoid System (ECS) Summarize the overall function of the ECS Identify various therapeutic actions of cannabinoids/terpenes/cannabis Compare and contrast THC and CBD Describe alternative methods of cannabis administration other than smoking….
Read more

Continuing Education Seminar, Medical Cannabis, Tennessee

, , , ,

Coming up Sept. 29 in Louisville, KY: The Endocannabinoid System and Cannabis: What Nurses Need to Know

Follow Us!Share This! The Endocannabinoid System and Cannabis: What Nurses Need to Know With Guest Presenter: Mary Lynn Mathre, RN, MSN, CARN, a medical cannabis consultant and addictions nurse consultant, co-founder of Patients Out of Time Friday, September 29, 2017 9:00 am- 4:05 pm Holiday Inn Louisville East- Hurstbourne Patient care is your #1 priority, which is why you are great at what you do! RN’s, NP’s, ARNP’s in all areas of practice, especially; pain management, hospice, palliative care, geriatrics,…
Read more

Continuing Education Seminar, Medical Cannabis, Therapeutic Effects

, , ,